Olive Leaf Compound Could Treat Malignant Mesothelioma
Author: Cancer Monthy
Published: 2015/12/27
Topic: Mesothelioma - Publications List
Page Content: Synopsis Introduction Main
Synopsis: Researchers say a compound found in the leaves of olive trees could eventually form the basis of a new treatment for mesothelioma.
Introduction
Mesothelioma researchers in Italy say they have found "antiproliferative properties" in the compound that gives olive oil its bitter taste. The discovery may help slow the spread of the aggressive asbestos cancer. Surviving Mesothelioma has just posted an article on the new research.
Main Item
Carla Marchetti of the Consiglio Nazionale delle Ricerche in Genova and a team of Italian colleagues applied a phenylethanoid called oleuropein to mesothelioma cells in the lab.
According to a report in Evidence-Based Complementary and Alternative Medicine, oleuropein slowed the rapid cell growth and division that make mesothelioma so deadly.
"Data suggest that our oleuropein-enriched fraction from olive leaf extract could have pharmacological application in malignant mesothelioma anticancer therapy," writes Dr. Marchetti.
"It is always encouraging when a new compound - especially one that is naturally-derived - is found to have an impact on mesothelioma since conventional treatments have limited success," says Alex Strauss, Surviving Mesothelioma's Managing Editor.
To read more about the oleuropein study and its potential impact on the future of mesothelioma treatment, see Olive Leaf Compound Could Lead to New Mesothelioma Treatment, available now on the Surviving Mesothelioma website (survivingmesothelioma.com).
Marchetti, C, et al, "Oleuropein-Enriched Olive Leaf Extract Affects Calcium Dynamics and Impairs Viability of Malignant Mesothelioma Cells", 2015, Evidence-Based Complementary and Alternative Medicine, Epub ahead of print, www.hindawi.com/journals/ecam/2015/908493/
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma.
All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.
1 - HXR9 Drug for Mesothelioma Cancer - Study reveals drug HRX9, that works by preventing cancer cells from avoiding apoptosis, shows promise for mesothelioma lung cancer.
2 - Olive Leaf Compound Could Treat Malignant Mesothelioma - Researchers say a compound found in the leaves of olive trees could eventually form the basis of a new treatment for mesothelioma.
3 - Total Ban on Asbestos in U.S. Sought by Steve McQueen's Widow - Barbara McQueen trying to convince federal law makers to finally ban the sale and use of asbestos in the United States.
Information and Page References
Disabled World (DW) is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Cancer Monthy. (2015, December 27). Olive Leaf Compound Could Treat Malignant Mesothelioma. Disabled World (DW). Retrieved January 15, 2025 from www.disabled-world.com/health/cancer/mesothelioma/olive-Leaves.php
Permalink: <a href="https://www.disabled-world.com/health/cancer/mesothelioma/olive-Leaves.php">Olive Leaf Compound Could Treat Malignant Mesothelioma</a>: Researchers say a compound found in the leaves of olive trees could eventually form the basis of a new treatment for mesothelioma.
While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.